HIV Treatment Innovation Module 6: Applying HIV Treatment Individualization in Patient Case Scenarios
September 30, 2025This module offers comprehensive patient cases that require learners to apply knowledge from Modules 1-5 in case-based scenarios.
HIV Treatment Innovation Module 2: Management of Common Comorbidities for People Living with HIV
This module provides considerations for managing and preventing common comorbidities, co-infections and opportunistic infections among PWH.
HIV Treatment Innovation Module 3: A Focus on Aging and Long-Term Survivors
This module provides considerations for managing HIV care among older adults and long-term HIV survivors.
HIV Treatment Innovation Module 4: Improving Health Equity in HIV Management
This module provides evidence-based HIV treatment optimization strategies for delivering quality HIV care among key populations.
HIV & Comorbidities: Understanding the Intersection of HIV and Other Health Conditions
September 29, 2025This webinar examines the impact of co-morbidities such as diabetes, cardiovascular disease, mental health disorders, and hepatitis on individuals living with HIV. Experts will discuss how these conditions intersect with HIV and influence treatment and health outcomes.
Transforming PrEP Navigation and Empowering Patients through Long-acting Injectable PrEP
September 18, 2025This webinar covers patient navigation touchpoints along the PrEP continuum for injectable lenacapavir, patient education strategies, expanding the capacity of PrEP navigation staff to implement injectable PrEP, and future opportunities for expanded implementation in mobile health settings.
Lenacapavir in Clinical Practice – A Primer for Clinicians
In the first webinar of the series, faculty – including principal investigators from the PURPOSE trials – review clinical data and delve into opportunities and challenges for the real-world implementation of lenacapavir as PrEP.
This webinar covers medication administration, managing side effects, potential drug interactions, and transitioning patients on or off lenacapavir as PrEP.
Comprehensive, Evidence-Based, Consensus Guidelines for Prescription of Opioids for Chronic Non-Cancer Pain from the American Society of Interventional Pain Physicians (ASIPP)
August 1, 2025This webinar offers a focused overview of the 2023 Clinical Practice Guidelines from the American Society of Interventional Pain Physicians (ASIPP), highlighting evidence-based strategies for prescribing opioids to manage chronic non-cancer pain.
Engaging African Immigrants in HIV Prevention and Care
July 24, 2025Engaging African Immigrants in HIV Prevention and Care is a self-paced e-learning course designed to equip healthcare and service providers with culturally responsive strategies to improve HIV prevention, testing, and care engagement among African immigrant communities.
CDC Clinical Practice Guidelines for Prescribing Opioids for Pain
May 7, 2025This webinar will cover the CDC Clinical Practice Guideline for Prescribing Opioids for Pain, focusing on key recommendations, patient safety strategies, and practical approaches for effective pain management.
HIVPCP Module 8 | Pharmacy-Based HIV Prevention and PrEP (HIVPCP℞)
April 2, 2025Module 8 of the HealthHIV HIV Prevention Certified Provider Certification Program. Pharmacists who complete the seven core modules of the HealthHIV’s HIVPCP Certification Program along with this newly released Pharmacy-Based HIV Prevention and PrEP module can earn the HIVPCP℞ specialty certification.
HIVPCP Module 7 | State of HIV Prevention and PrEP in 2025: Certification Maintenance for HIVPCPs
Module 7 of the HealthHIV HIV Prevention Certified Provider Certification Program. This course provides an update on the current state of the HIV epidemic, key biomedical advances in HIV prevention, and evidence-based approaches to HIV prevention.
